Meditek Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.50 M
as on 04-07-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.09 Cr
as on 04-07-2024
- Revenue -32.75%
(FY 2023)
- Profit 16.72%
(FY 2023)
- Ebitda 11.81%
(FY 2023)
- Net Worth 47.38%
(FY 2023)
- Total Assets -28.89%
(FY 2023)
About Meditek Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.09 Cr.
Tushar Ganatra, Rina Shah, Mehul Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC041982
- Company No.
041982
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Meditek Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Shah  | Managing Director | 11-Feb-2003 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kushan Shah | Director | 18-May-2016 | Current |
| Tushar Ganatra | Director | 16-Nov-2021 | Current |
| Rina Shah | Whole-Time Director | 11-Feb-2003 | Current |
Financial Performance of Meditek Life Sciences.
Meditek Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.75% decrease. The company also saw a substantial improvement in profitability, with a 16.72% increase in profit. The company's net worth Soared by an impressive increase of 47.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditek Life Sciences?
In 2023, Meditek Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Leo Life Sciences Private LimitedActive 21 years 5 monthsTushar Ganatra, Rina Shah and 2 more are mutual person
- Leo Marketing Private LimitedActive 30 years 8 months
Rina Shah, Mehul Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Aug 2022 | ₹0.91 M | Open |
Sidbi Creation Date: 17 Mar 2022 | ₹5.00 M | Open |
Sidbi Creation Date: 03 Jun 2020 | ₹5.00 M | Open |
How Many Employees Work at Meditek Life Sciences?
Meditek Life Sciences has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditek Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditek Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
